PERSPECTA

News from every angle

Back to headlines

NeuroScientific Reports 80% Clinical Response in Crohn's Stem Cell Program

NeuroScientific has announced an 80% clinical response rate in its stem cell program for Crohn's disease, marking a significant development in treatment research.

26 May, 02:02 — 26 May, 02:02
PostShare